Literature DB >> 12171045

Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium.

J B Wong1, F Nevens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171045

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


× No keyword cloud information.
  3 in total

1.  Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.

Authors:  Ru Han; Clément François; Mondher Toumi
Journal:  Appl Health Econ Health Policy       Date:  2021-01       Impact factor: 2.561

2.  The current economic burden of cirrhosis.

Authors:  Guy W Neff; Christopher W Duncan; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach.

Authors:  Ru Han; Shuyao Liang; Clément François; Samuel Aballea; Emilie Clay; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2021-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.